BeOne Medicines Ltd. - 8-K Filing

BeOne Medicines Ltd. filed to disclose the conclusion of a statutory tax audit in China and agreed to an income tax payment of approximately RMB 446 million (including surcharges and interest) as part of a settlement with local authorities, which will be recognized in its Q2 fiscal 2026 U.S. GAAP financial statements. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $ONC

Read the full article at SEC EDGAR

More Regulatory news